Ex. 2001 - USP 9,757,384 B2 (Cowen) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 1 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 2 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 3 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 4 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 5 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 6 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 7 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 8 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 9 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 10 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 11 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2002 - USP 9,757,384 B2 FH - Part 12 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2003 - USP 12,419,895 B1 Family Tree | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2004 - USP Appl Publ No. US 2016-0136178 A1 (Cowen) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2006 - Soleno Therapeutics, Inc. SEC Form 10-K (YE 2017) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2007 - Soleno News Release - 4Q & Full-Year 2018 Financial Results (Globenewswire 3.18.2019) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2008 - Soleno News Release - 4Q & Full-Year 2019 Financial Results (Globenewswire 3.4.2020) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2009 - Soleno News Release - 4Q & Full-Year 2020 Financial Results (Globenewswire 3.3.2021) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2010 - Soleno News Release - 4Q & Full-Year 2021 Financial Results (Globenewswire 3.31.2022) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2011 - Soleno News Release - 4Q & Full-Year 2022 Financial Results (Globenewswire 3.21.2023) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2012 - Soleno News Release - 4Q & Full-Year 2023 Financial Results (Globenewswire 3.6.2024) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2013 - Soleno News Release - 4Q & Full-Year 2024 Financial Results (Globenewswire 2.27.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2014 - BioSpace Press Release - VYKAT XR Launch Update & Soleno 1Q 2025 Financial Results (5.8.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2015 - Apotex, Generics - A Force for Accessible Medicine | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2016 - Aptoex, What We’ve Created | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2017 - FDA, Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2018 - FDA, Search Orphan Drug Designations and Approvals - VykatXR | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2019 - NIH, ClinicalTrials.gov, Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities (9.8.2022) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2020 - NIH, ClinicalTrials.gov, Study of Diazoxide Choline in Patients With PWS (9.21.2023) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2021 - NIH, ClinicalTrials.gov, Open-Label Extension Study of DCCR in PWS (4.19.2024) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2022 - NIH, ClinicalTrials.gov, PWS Outcomes Assessment Study (11.4.2024) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2023 - NIH, ClinicalTrials.gov, Open-Label Extension Study of DCCR in Patients With PWS (4.2.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2024 - NIH, ClinicalTrials.gov, Observational Study of VYKAT XR in Patients With PWS (5.19.2026) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2025 - PWSA Blog, Breaking News! FDA Approves 1st-EverTreatment for Hyperphagia in PWS (3.26.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2026 - PWSA Blog, With New Treatment Comes Renewed Hope (3.27.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2027 - KKF Health News, Revolutionary Drug for Extreme Hunger... (6.16.2025) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2028 - Neurocrine, Neurocrine to Acquire Soleno... (4.6.2026) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2029 - USPTO, FAQs for Interim Processes for PTAB Workload Management | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2030 - USPTO, Dir. Mem., Add'l Discretionary Inst. Considerations (3.11.2026) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2031 - Aptoex Petition & Expert Declaration Comparison | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2032 - Jabri-Shumaker emails Re Vykat XR Orange Book Patent - Petition for Post Grant Review (5.15.2026) | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2033 - Apotex CREATES Act Request 01.06.2026 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2034 - Apotex CREATES Act Request 02.13.26 | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Ex. 2005 - Declaration of Ramesh Tharuvai | Jun 22, 2026 | EXHIBIT | PATENT OWNER |
Patent Owner's Brief on Discretionary Denial | Jun 22, 2026 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | May 11, 2026 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | May 11, 2026 | PAPER | PATENT OWNER |
Notice filing date accorded | Apr 22, 2026 | PAPER | BOARD |
Petition: as filed | Apr 21, 2026 | PAPER | PETITIONER |
EX1001 U.S. Patent No. 12,419,895 to Cowen | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1002 Orange Book Vykat | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1003 Organic Chemistry | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1004 Vykat Package Insert | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1005 Declaration of Dr. Hollander | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1006 Curriculum Vitae of Dr. Hollander | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1007 Cassidy | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1008 International Patent Pub. No. WO 2014/197753 to Cotter | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1010 Ashcroft | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1011 Hyperstat Diazoxide | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1012 Proglycem Diazoxide | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1013 Remington | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX 1014 FDA Guidance | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1015 U.S. Patent No. 12,419,895 File History | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1016 U.S. Patent Pub. No. 2014/0364367 to Cotter | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1017 Miller | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1018 PDR 2008 | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1009 WO2009006483 - Cowen Part 1 | Apr 21, 2026 | EXHIBIT | PETITIONER |
EX1009 WO2009006483 - Cowen Part 2 | Apr 21, 2026 | EXHIBIT | PETITIONER |
Notice: Power of Attorney | Apr 21, 2026 | PAPER | PETITIONER |